Improving communication, building relationships, coordinating activities among units, and engaging staff members are not only ways to create a more positive working environment, they are critical for maintaining patient safety.
Oncology Nursing Society President Carlton Brown Describes the ONS Social Media Efforts
Halle Moore, MD, medical oncologist, Cleveland Clinic, discusses survivorship issues and symptoms that breast cancer survivors face.
Yuhong Dong, MD, PhD, clinical researcher at Novartis, discusses the benefits of practicing Falun Gong for patients with terminal cancer.
Adam Dicker explains the benefit of nurses when communicating with patients, and how they help to combat "white coat syndrome."
As both patient advocate and educator, the ONN partners with physicians to help support the cancer patient's journey throughout the course of disease, with the ultimate goal of improving care and outcomes.
As genetic testing becomes increasingly available, there will be a growing gap between the wide availability of testing and the relative importance of results to treatment decisions. In the current environment, there's more promise in precision medicine than practical applications in the exam room.
Cancer immunotherapies continue to show promising clinical outcomes, notably long-lasting remission, for an increasing number of malignancies.
At the 2019 Hairy Cell Leukemia Foundation Annual Conference new findings showed promise in the safety of vemurafenib to treat patients with hairy cell leukemia.
The median overall survival for patients with chronic lymphocytic leukemia has more than tripled since the 1970s, primarily due to an ever-expanding armamentarium of novel agents and earlier diagnosis.
Donna L. Berry, PhD, RN, AOCN, FAAN, Director, Phyllis F. Cantor Center for Research in Nursing & Patient Care Services, Dana-Farber Cancer Institute, Associate Professor, Department of Medicine, Harvard Medical School, discusses decision support for men with localized prostate cancer.
Jessica Goldberg, MSN, adult gerontology nurse practitioner, fellow in palliative medicine, Memorial Sloan Kettering Cancer Center, discusses the results of a study in which a cancer self-management intervention was created for patients with breast cancer.
Being obese at the time operable breast cancer is diagnosed is associated with inferior outcomes in women with estrogen receptor (ER) or progesterone receptor (PR)positive, HER2-negative breast cancer.
Due to their strict regulations, clinical trials eliminate room for discriminatory practices, and can lend insight to disparities among groups.
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Nurses should be aware of patients who are at risk for immunotherapy-related myocarditis.
Every day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.
For patients with advanced prostate cancer, new findings from the CARD trial could change their daily treatment.
Caregivers of people with cancer should get flu shots.
Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses when he administers Radium-223 in his practice.
Monica Knoll is no stranger to cancer. Her sister is a breast cancer survivor and her father died from esophageal cancer. Still, she was not prepared for a breast cancer diagnosis in 2000
Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses the impact myeloproliferative neoplasms can have on patients' quality of life.
The call bell light in room 12-204 was the first to go off at the crack of dawn, breaking the serene silence of the floor. “I need to shower so I can see the race!” the patient exclaimed.
E. David Crawford, MD, professor of radiation oncology University of Colorado Denver, discusses the potential side effects of frequently used prostate cancer treatments.
Norman E. Sharpless, MD, Professor of Medicine & Genetics Chair, The Lineberger Comprehensive Cancer Center, discusses a recent study that evaluated sunscreen’s effectiveness in reducing melanoma risk.